全文获取类型
收费全文 | 1877篇 |
免费 | 142篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 55篇 |
妇产科学 | 18篇 |
基础医学 | 223篇 |
口腔科学 | 52篇 |
临床医学 | 169篇 |
内科学 | 466篇 |
皮肤病学 | 248篇 |
神经病学 | 199篇 |
特种医学 | 105篇 |
外科学 | 172篇 |
综合类 | 16篇 |
预防医学 | 147篇 |
药学 | 78篇 |
肿瘤学 | 86篇 |
出版年
2018年 | 12篇 |
2017年 | 15篇 |
2016年 | 36篇 |
2015年 | 39篇 |
2014年 | 38篇 |
2013年 | 80篇 |
2012年 | 32篇 |
2011年 | 48篇 |
2010年 | 46篇 |
2009年 | 64篇 |
2008年 | 53篇 |
2007年 | 57篇 |
2006年 | 61篇 |
2005年 | 38篇 |
2004年 | 36篇 |
2003年 | 38篇 |
2002年 | 27篇 |
2001年 | 33篇 |
2000年 | 38篇 |
1999年 | 56篇 |
1998年 | 74篇 |
1997年 | 62篇 |
1996年 | 63篇 |
1995年 | 58篇 |
1994年 | 62篇 |
1993年 | 43篇 |
1992年 | 73篇 |
1991年 | 30篇 |
1990年 | 54篇 |
1989年 | 60篇 |
1988年 | 80篇 |
1987年 | 53篇 |
1986年 | 51篇 |
1985年 | 37篇 |
1984年 | 45篇 |
1983年 | 21篇 |
1982年 | 23篇 |
1981年 | 23篇 |
1980年 | 18篇 |
1978年 | 20篇 |
1977年 | 13篇 |
1976年 | 13篇 |
1975年 | 10篇 |
1974年 | 8篇 |
1973年 | 9篇 |
1972年 | 11篇 |
1971年 | 12篇 |
1968年 | 10篇 |
1966年 | 11篇 |
1964年 | 14篇 |
排序方式: 共有2041条查询结果,搜索用时 31 毫秒
31.
32.
Stephen PH Alexander 《British journal of pharmacology》2012,167(8):1573-1574
33.
34.
35.
Interleukin-3, GM-CSF, and TPA induce distinct phosphorylation events in an interleukin 3-dependent multipotential cell line 总被引:9,自引:0,他引:9
The mechanism of action of the hemopoietic growth factor, murine interleukin-3 (mIL-3), was investigated using an mIL-3-dependent multipotential hematopoietic cell line, B6SUtA1. Murine granulocyte- macrophage colony-stimulating factor (mGM-CSF) was as potent as mIL-3 in stimulating these cells. In addition, sodium orthovanadate, an inhibitor of phosphotyrosine phosphatase, and 12-O-tetradecanoyl- phorbol-13-acetate (TPA), a known activator of protein kinase C, also stimulated DNA synthesis in these cells, suggesting that protein phosphorylation might be involved in the mechanism of action of mIL-3 and mGM-CSF. To assess this possibility, intact B6SUtA1 cells exposed for brief periods to mIL-3, mGM-CSF, and TPA were analyzed for changes in phosphorylation patterns using metabolic 32P-labeling and antibodies to phosphotyrosine. Both mIL-3 and mGM-CSF induced the serine-specific phosphorylation of a 68-Kd cytosolic protein, whereas all three agents stimulated the serine-specific phosphorylation of a 68-Kd membrane protein. Furthermore, mIL-3 stimulated tyrosine phosphorylation of the 68-Kd membrane protein, as well as of 140-, 90-, 55, and 40-Kd proteins. The 90-Kd protein was also tyrosine phosphorylated in response to mGM-CSF. These phosphotyrosine containing proteins were not detected in TPA-treated cells. These results indicate that protein phosphorylations on tyrosine and serine residues occur in B6SUtA1 cells following short-term incubation with mIL-3 or mGM-CSF and that most of these phosphorylation events are mediated by kinases other than protein kinase C (PkC). 相似文献
36.
The plasma clotting factors used to treat hemophiliacs who have developed inhibitory antibodies have a shared history of limited clinical safety and utility. To improve on existing bypass factors, we have developed a reversibly acylated form of human plasma factor Xa capable of providing a time-dependent release of procoagulant activity. Factor Xa was treated with p-amidinophenyl p'-anisate to generate anisoyl Xa. The chemical modification of the protein involves acylation of the active site serine residue of factor Xa. Anisoyl Xa deacylated in a time, pH, and temperature-dependent manner. Active factor Xa generated on deacylation of anisoyl Xa exhibited amidolytic and prothrombinase complex activities in in vitro assays, the level being comparable to those of untreated factor Xa. When Anisoyl Xa was infused into rabbits, active factor Xa was generated on deacylation of the acylated enzyme, which shortened the activated partial thromboplastin time (APTT) in a dose-dependent manner. The duration of effect on rabbit APTT could be directly correlated to the level of human plasma factor Xa. Because anisoyl Xa bypasses the "tenase" complex that is compromised in hemophilia A and B and is unaffected by inhibitory antibodies, it has the potential to be used as an effective bypass therapy. 相似文献
37.
Follicle lysis is a characteristic alteration of B cell follicles described recently in lymph node biopsies from homosexual men. It consists of disruption of germinal centers by aggregates of small mature lymphocytes variably associated with erythrocyte extravasation. We studied the immunohistology of follicle lysis identified in lymph node biopsies from 11 homosexual men. The results indicate that follicle lysis has two principal immunohistologic features: (1) intrafollicular aggregates of small lymphocytes predominantly of polytypic mantle B cell phenotype (T015+/Leu-8+/mu+/delta+/k+ or lambda+), and (2) disruption of the normal, unified follicular meshwork of R4/23+ dendritic reticulum cells by these B cell aggregates. These structural alterations may affect the functional integrity of the germinal center as it pertains to the abnormal B cell effector function and the increased prevalence of B cell lymphoma recently documented in the acquired immunodeficiency syndrome and related disorders. Because dendritic reticulum cells weakly express the Leu-3 (T4) antigen, which is known to be an essential component of the receptor for human T- lymphotropic virus type III/lymphadenopathy-associated virus (HTLV- III/LAV) retrovirus infection, it is possible that retroviral infection of dendritic reticulum cells may play a role in the pathogenesis of follicle lysis. 相似文献
38.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
39.
40.